A pacemaker is a marvel of medical engineering, a tiny yet powerful device designed to manage and regulate the rhythm of the heart. Implantable within the body, this technological marvel plays a crucial role in maintaining a steady heartbeat. Through the emission of carefully calibrated electrical pulses, the pacemaker takes charge of orchestrating the heart's rhythm, providing a lifeline for those grappling with irregular heartbeats or conditions affecting the heart's intrinsic pacemaking system. For individuals facing cardiac challenges, the pacemaker serves as a silent guardian, continuously monitoring the heart's every beat. When irregularities arise, the pacemaker intervenes, ensuring that the heart beats in a synchronized and efficient manner. This intervention is pivotal in enhancing the overall quality of life for patients, alleviating symptoms associated with heart rhythm abnormalities.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States